10 Einträge gefunden

1. Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery:A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD

   1. Bonaca, Marc P
   2. Szarek, Michael
   3. Debus, E Sebastian
   4. Nehler, Mark R
   5. Patel, Manesh R
   6. Anand, Sonia S
   7. Muehlhofer, Eva

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial:Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone

   1. Berkowitz, Scott D
   2. Bauersachs, Rupert M
   3. Szarek, Michael
   4. Nehler, Mark R
   5. Debus, E Sebastian
   6. Patel, Manesh R
   7. Anand, Sonia S

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial:The XATOA Registry

   1. Fox, Keith A A
   2. Aboyans, Victor
   3. Debus, E Sebastian
   4. Zeymer, Uwe
   5. Cowie, Martin R
   6. Patel, Manesh
   7. Welsh, Robert C

   2022 - Forschungsinformationssystem des UKE
4. Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization:Insights From VOYAGER PAD

   1. Hess, Connie N
   2. Baumgartner, Iris
   3. Anand, Sonia S
   4. Nehler, Mark R
   5. Patel, Manesh R
   6. Debus, E Sebastian
   7. Szarek, Michael

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization

   1. Hess, Connie N
   2. Szarek, Michael
   3. Anand, Sonia S
   4. Bauersachs, Rupert M
   5. Patel, Manesh R
   6. Debus, E Sebastian
   7. Nehler, Mark R

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
6. Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial

   1. Bauersachs, Rupert M
   2. Szarek, Michael
   3. Brodmann, Marianne
   4. Gudz, Ivan
   5. Debus, Eike Sebastian
   6. Nehler, Mark R
   7. Anand, Sonia S

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

   1. Debus, Sebastian
   2. Nehler , Mark R
   3. Govsyeyev, Nicholas
   4. Bauersachs, Rupert M
   5. Anand, Sonia S
   6. Patel, Manesh R
   7. Fanelli, Fabrizio

   2021 - Forschungsinformationssystem des UKE
8. Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both

   1. Fox, Keith A A
   2. Anand, Sonia S
   3. Aboyans, Victor
   4. Cowie, Martin R
   5. Debus, E Sebastian
   6. Zeymer, Uwe
   7. Monje, Danja

   2020 - Forschungsinformationssystem des UKE
9. Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization:Impact of Concomitant Clopidogrel on Efficacy and Safety

   1. Hiatt, William R
   2. Bonaca, Marc P
   3. Patel, Manesh R
   4. Nehler, Mark R
   5. Debus, Eike Sebastian
   6. Anand, Sonia S
   7. Capell, Warren H

   2020 - Forschungsinformationssystem des UKE - frei zugänglich
10. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance

    1. Mente, Andrew
    2. Razak, Fahad
    3. Blankenberg, Stefan
    4. Vuksan, Vlad
    5. Davis, A Darlene
    6. Miller, Ruby
    7. Teo, Koon

    2010 - Forschungsinformationssystem des UKE